AFP and cancer: Specific glycoproteins incorporating aberrant glycans have been uncovered with significantly higher specificity for cancers than the proteins themselves, such as glycosylated alpha-fetoprotein (AFP), which serves as a more reliable marker for hepatocellular carcinoma (HCC) than AFP protein [21,22].